Impact of cardiologist intervention on guideline-directed use of statin therapy.
Adherence
Ambulatory care
Cardiologist
Guideline directed statin therapy
Statin use
Journal
World journal of cardiology
ISSN: 1949-8462
Titre abrégé: World J Cardiol
Pays: United States
ID NLM: 101537090
Informations de publication
Date de publication:
26 Aug 2020
26 Aug 2020
Historique:
received:
28
02
2020
revised:
13
05
2020
accepted:
01
08
2020
entrez:
4
9
2020
pubmed:
4
9
2020
medline:
4
9
2020
Statut:
ppublish
Résumé
Statins have an important and well-established role in the prevention of atherosclerotic cardiovascular disease (ASCVD). However, several studies have reported widespread underuse of statins in various practice settings and populations. Review of relevant literature reveals opportunities for improvement in the implementation of guideline-directed statin therapy (GDST). To examine the impact of cardiologist intervention on the use of GDST in the ambulatory setting. Patients with at least one encounter at the adult Internal Medicine Clinic (IMC) and/or Cardiology Clinic (CC), who had an available serum cholesterol test performed, were evaluated. The 2 comparison groups were defined as: (1) Patients only seen by IMC; and (2) Patients seen by both IMC and CC. Patients were excluded if variables needed for calculation of ASCVD risk scores were lacking, and if demographic information lacked guideline-directed treatment recommendations. Data were analyzed using student A total of 268 patients met the inclusion criteria for this study; 211 in the IMC group and 57 in the IMC-CC group. Overall, 56% of patients were female, mean age 56 years (± 10.65, SD), 22% Black or African American, 56% Hispanic/Latino, 14% had clinical ASCVD, 13% current smokers, 66% diabetic and 63% hypertensive. Statin use was observed in 55% ( Although overall use of GDST was suboptimal, there was no statistical difference in appropriate statin use based on guidelines between groups managed by general internists alone or co-managed with a cardiologist. These findings highlight the need to design and implement strategies to improve adherence rates to GDST across all specialties.
Sections du résumé
BACKGROUND
BACKGROUND
Statins have an important and well-established role in the prevention of atherosclerotic cardiovascular disease (ASCVD). However, several studies have reported widespread underuse of statins in various practice settings and populations. Review of relevant literature reveals opportunities for improvement in the implementation of guideline-directed statin therapy (GDST).
AIM
OBJECTIVE
To examine the impact of cardiologist intervention on the use of GDST in the ambulatory setting.
METHODS
METHODS
Patients with at least one encounter at the adult Internal Medicine Clinic (IMC) and/or Cardiology Clinic (CC), who had an available serum cholesterol test performed, were evaluated. The 2 comparison groups were defined as: (1) Patients only seen by IMC; and (2) Patients seen by both IMC and CC. Patients were excluded if variables needed for calculation of ASCVD risk scores were lacking, and if demographic information lacked guideline-directed treatment recommendations. Data were analyzed using student
RESULTS
RESULTS
A total of 268 patients met the inclusion criteria for this study; 211 in the IMC group and 57 in the IMC-CC group. Overall, 56% of patients were female, mean age 56 years (± 10.65, SD), 22% Black or African American, 56% Hispanic/Latino, 14% had clinical ASCVD, 13% current smokers, 66% diabetic and 63% hypertensive. Statin use was observed in 55% (
CONCLUSION
CONCLUSIONS
Although overall use of GDST was suboptimal, there was no statistical difference in appropriate statin use based on guidelines between groups managed by general internists alone or co-managed with a cardiologist. These findings highlight the need to design and implement strategies to improve adherence rates to GDST across all specialties.
Identifiants
pubmed: 32879704
doi: 10.4330/wjc.v12.i8.419
pmc: PMC7439448
doi:
Types de publication
Journal Article
Langues
eng
Pagination
419-426Informations de copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: No conflicts of interest exist for any of the authors relating to this study.
Références
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Circulation. 2019 Jun 18;139(25):e1082-e1143
pubmed: 30586774
Am J Cardiol. 2016 Jan 1;117(1):48-53
pubmed: 26589821
Circulation. 2011 Nov 29;124(22):2405-10
pubmed: 22064595
Diabetes Educ. 2016 Apr;42(2):228-33
pubmed: 26902526
J Am Heart Assoc. 2019 Feb 5;8(3):e010241
pubmed: 30681391
J Am Heart Assoc. 2015 Mar 10;4(3):e001597
pubmed: 25758604
Am J Med. 2015 Apr;128(4):403-9
pubmed: 25460526
J Am Coll Cardiol. 2019 Nov 19;74(20):2525-2528
pubmed: 31727291
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):560-6
pubmed: 26555123
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934
pubmed: 24239923
N Engl J Med. 2014 Apr 10;370(15):1422-31
pubmed: 24645848
Circulation. 1999 Mar 2;99(8):E1-7
pubmed: 10051310
JAMA Cardiol. 2017 Apr 1;2(4):361-369
pubmed: 28249067